China-CEEC trade rises 11% in first half, customs data shows

BEIJING, July 16, 2026 /PRNewswire/ -- This is a report from China SCIO Trade between China and Central and Eastern European countries (CEEC) rose 11% year on year to 580.12 billion yuan (US$85.57 billion) in the first half of this year, continuing

Clinicians Are Adopting AI to Solve the Documentation Crisis, New Global Survey Finds

New report finds 83% of clinicians adopted AI while workplace guidance and governance frameworks were still being developed. NEW YORK, July 16, 2026 /PRNewswire/ -- A survey of 1,823 clinicians across 25 countries has found healthcare professionals

Telix Opens Australian-First Facility to Accelerate Delivery of New Cancer Treatments and Expand Sovereign Manufacturing

First-of-its-kind facility in Australia where radiopharmaceuticals are developed, manufactured and administered to patients under one roof. Patient care and research delivered in collaboration with the Melbourne Theranostic Innovation Centre

Coremail Presents AI-Native Secure Email System at LEAP East 2026

HONG KONG, July 16, 2026 /PRNewswire/ -- From July 8 to 10, 2026, Coremail participated in the Asia LEAP East International Technology and Information Technology Exhibition 2026 held in Hong Kong, showcasing its Coremail AI-Native Secure Email

Japanese investors offered final opportunity to own at Chelsea Residences by DAMAC in Dubai

TOKYO, July 16, 2026 /PRNewswire/ -- DAMAC Properties, the largest private real estate developer in the UAE and the Middle East, is set to unveil the sixth and final tower of Chelsea Residences by DAMAC at the Grand Ballroom, Mandarin Oriental on

Copyright Cases Dominate as Regulatory and Product Liability Challenges Emerge in the Q2 2026 J.S. Held AI Disputes Monitor

Content-creator litigation grows more sophisticated as courts are asked to weigh in on how AI regulation. NEW YORK, July 16, 2026 /PRNewswire/ -- Global consulting firm J.S. Held today releases the Q2 2026 J.S. Held AI Disputes Monitor, the firm's

First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer

First patients dosed in OPTIMAL-e[1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier prostate cancer treatment setting, building on

Webull Corporation Reports June 2026 Operating Data

ST. PETERSBURG, Fla., July 16, 2026 /PRNewswire/ -- Webull Corporation (NASDAQ: BULL) today reported select monthly operating data for June 2026. Registered Users at the end of June were 28.2 million (up approximately 200 thousand from the end of

Business leaders call for stronger partnerships to accelerate sustainable development at 2026 SDG Business Forum

NEW YORK, July 16, 2026 /PRNewswire/ -- Business leaders, policymakers, United Nations officials and representatives from civil society came together yesterday at the 2026 SDG Business Forum to highlight the critical role of responsible business in

OMAN'S US$5.2 BILLION FUTURE FUND UNVEILS US$1.744 BILLION IN PROJECTS

MUSCAT, Oman, July 16, 2026 /PRNewswire/ -- Future Fund Oman (FFO), a portfolio of Oman Investment Authority (OIA), the Sultanate of Oman's sovereign wealth fund, has announced a new package of 105 strategic projects and investments worth USD 1.744